UbiVac

Biotechnology, Health Care, Wellness

Founded in 1/1/05

Portland, Oregon, United States

http://www.ubivac.com/

For Profit

About UbiVac

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the Robert W. Franz Cancer Research Center within the Earle A. Chiles Research Institute, at Providence Portland Medical Center, UbiVac continues to build upon the groundbreaking research being developed in the region.

Company Metrics

Employees: 1-10
Monthly Visits: None
Tech Stack: None active products

Financial Information

Estimated Revenue:
Total Funding: 2195773 USD
Last Funding: 250000 USD (Seed)
Funding Status: Seed

Technology Stack

UbiVac actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Wellness

Headquarters: Portland, Oregon, United States

Leadership